What I'm buying, Simavita Ltd (SVA)

Dean Honan


What I'm buying, Simavita Ltd (SVA). Medical Device Company that has developed an innovative solution for the assessment of urinary Incontinence, with a focus on the elderly. Currently there are 15 million plus incontinence assessments per year that result in $6 billion of labour costs. SIM is a wireless sensor technology which delivers instrumented Incontinence Assessments that result in 25% product cost reduction, 23% decrease in landfill and 21% improvement in effective toileting. I attended a management presentation earlier this week and was very impressed with CEO Philippa Lewis who has 25 years in the industry. Currently supplying their technology to $7bn firm Medline, which is the leading provider of adult incontinence products to the US healthcare market, you can be sure traction is imminent. The company expects global revenue to commence this quarter out of the US which will be a significant catalyst. CP $0.90, TP $1.09

Dean Honan
Dean Honan
Senior Stockbroker

I am a senior stockbroker with close to a decade of experience in financial markets. Prior to joining Morgans I held senior advisory roles with Morgan Stanley and UBS AG


No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.


Sign In or Join Free to comment